Registrational Phase 3 study for advanced melanoma immunotherapy delivered with PharmaJet's IM Needle-free System planned for ...
Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...
What began as a casually shared image on social media soon turned into a serious health discussion after a woman posted a photograph of faint black lines on her thumb and toe nails, prompting ...
Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the ...
Letter: Dr Carol S Leonard writes that mRNA vaccines are a way forward for those with melanoma, but hopes are dashed by financial cuts ...
Tim Allen revealed to Bill Maher that he was diagnosed with skin cancer that was initially "missed five times" by a ...
iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference -- Participation underscores growing excitement around company's momentum and potential in precision oncology ...
Eikon's most advanced product candidate is EIK1001, a toll-like receptor that is in phase 2/3 registrational trial in combination with pembrolizumab to treat patients with melanoma. Eikon recorded a ...
Life&Style Weekly on MSN
Why Max’s Mom Was Excluded from ‘Stranger Things’ Season 5, According to the Actress Who Played Her
Stranger Things may have officially closed the door on Hawkins, but one lingering question has left fans scratching their ...
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced a business ...
As of Friday, January 09, Galectin Therapeutics Inc.’s GALT share price has dipped by 6.56%, which has investors questioning ...
Grey’s Anatomy’s midseason premiere Jan. 8 revealed whether Jo Wilson and her and Atticus “Link” Lincoln’s twins survived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback